文献速递药疹与重症皮肤不良反应自身免疫性与大疱性皮肤病皮肤感染

COVID-19疫苗接种后的皮肤表现:世界文献综述与自身经验

Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2021-11-02

该综述概述了全球大规模COVID-19疫苗接种运动以来观察到的皮肤反应。注射部位非特异性反应最常见;I型超敏反应(如荨麻疹、血管性水肿、过敏反应)可能罕见但可严重;IV型超敏反应包括延迟性大局部皮肤病变(「COVID臂」)、填充剂或既往放疗部位及旧BCG瘢痕的炎症反应、麻疹样及多形红斑样皮疹。自身免疫介导的皮肤表现包括白细胞碎裂性血管炎、红斑狼疮和免疫性血小板减少症;功能性血管病(冻疮样病变、红斑肢痛症)也可能出现;已有报道玫瑰糠疹样皮疹和带状疱疹再激活。许多皮肤表现具有免疫/自身免疫性质,SARS-CoV-2与人类成分间的分子模拟可能解释部分病理及皮肤不良反应。

要点

  • 注射部位非特异性反应是接种后最常见的皮肤表现。
  • I型超敏反应可能罕见但可严重,IV型超敏反应包括「COVID臂」、填充剂/放疗部位炎症及麻疹样皮疹。
  • 自身免疫介导的皮肤表现包括白细胞碎裂性血管炎、红斑狼疮、免疫性血小板减少症,功能性血管病也可能出现。

核心结论

  • COVID-19疫苗接种后可能出现多种皮肤反应模式,许多具有免疫/自身免疫性质。
  • SARS-CoV-2与人类成分间的分子模拟可能解释部分COVID-19病理及疫苗接种后的皮肤不良反应。

研究设计与样本

  • 综述文章,概述全球大规模COVID-19疫苗接种运动以来观察到的皮肤表现,并结合自身经验。

主要发现

  • 注射部位非特异性反应最常见,且出现于接种后很早。
  • I型超敏反应(如荨麻疹、血管性水肿、过敏反应)可能由对成分过敏所致,罕见但可严重。
  • IV型超敏反应包括延迟性大局部皮肤病变(「COVID臂」)、填充剂或既往放疗部位及旧BCG瘢痕的炎症反应,以及更常见的麻疹样和多形红斑样皮疹。
  • 自身免疫介导的皮肤表现包括白细胞碎裂性血管炎、红斑狼疮和免疫性血小板减少症。
  • 功能性血管病(冻疮样病变、红斑肢痛症)、玫瑰糠疹样皮疹和带状疱疹再激活也有报道。

临床怎么用

  • 接种后应识别注射部位反应、超敏反应及自身免疫介导的皮肤表现,警惕罕见但可严重的I型超敏反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is growing evidence that not only the novel coronavirus disease (COVID-19) but also the COVID-19 vaccines can cause a variety of skin reactions. In this review article, we provide a brief overview on cutaneous findings that have been observed since the emerging mass COVID-19 vaccination campaigns all over the world. Unspecific injection-site reactions very early occurring after the vaccination are most frequent. Type I hypersensitivity reactions (e.g. urticaria, angio-oedema and anaphylaxis) likely due to allergy to ingredients may rarely occur but can be severe. Type IV hypersensitivity reactions may be observed, including delayed large local skin lesions ("COVID arm"), inflammatory reactions in dermal filler or previous radiation sites or even old BCG scars, and more commonly morbilliform and erythema multiforme-like rashes. Autoimmune-mediated skin findings after COVID-19 vaccination include leucocytoclastic vasculitis, lupus erythematosus and immune thrombocytopenia. Functional angiopathies (chilblain-like lesions, erythromelalgia) may also be observed. Pityriasis rosea-like rashes and reactivation of herpes zoster have also been reported after COVID-19 vaccination. In conclusion, there are numerous cutaneous reaction patterns that may occur following COVID-19 vaccination, whereby many of these skin findings are of immunological/autoimmunological nature. Importantly, molecular mimicry exists between SARS-CoV-2 (e.g. the spike-protein sequences used to design the vaccines) and human components and may thus explain some COVID-19 pathologies as well as adverse skin reactions to COVID-19 vaccinations.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Gambichler T, Boms S, Susok L, et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol. 2021. PMID: 34661927. doi:10.1111/jdv.17744

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。